Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petter Björquist

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Stem Cells (Dayton, Ohio)|March 25, 2011
Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessmentPeter Sartipy, Petter Björquist
Clinical and Translational Medicine|May 30, 2014
Employment of the Triple Helix concept for development of regenerative medicine applications based on human pluripotent stem cellsPeter Sartipy, Petter Björquist
Journal of Cellular Physiology|March 12, 2009
Human embryonic stem cell technologies and drug discoveryJanne Jensen, Johan Hyllner, Petter Björquist
Pharmacological Research|July 1, 2008
Low molecular weight compounds for in vitro fate determination of human embryonic stem cellsPeter Sartipy, Raimund Strehl, Petter Björquist, et al.
Drug Discovery Today|September 11, 2007
The application of human embryonic stem cell technologies to drug discoveryPeter Sartipy, Petter Björquist, Raimund Strehl, et al.
Biochemical Pharmacology|July 27, 2011
OATP1B1/1B3 activity in plated primary human hepatocytes over time in cultureMaria Ulvestad, Petter Björquist, Espen Molden, et al.
Stem Cells and Development|September 14, 2012
Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactorLouise Sivertsson, Jane Synnergren, Janne Jensen, et al.
Critical Reviews in Oncology/Hematology|August 11, 2007
Human embryonic stem cells: current technologies and emerging industrial applicationsCaroline Améen, Raimund Strehl, Petter Björquist, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 2, 2006
Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytesAnders Norström, Karolina Akesson, Thorir Hardarson, et al.
Thrombosis and Haemostasis|February 8, 2003
Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasmaJudith Leurs, Britt-Marie Wissing, Viveca Nerme, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Stem Cells (Dayton, Ohio)|March 25, 2011
Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessmentPeter Sartipy, Petter Björquist
Clinical and Translational Medicine|May 30, 2014
Employment of the Triple Helix concept for development of regenerative medicine applications based on human pluripotent stem cellsPeter Sartipy, Petter Björquist
Journal of Cellular Physiology|March 12, 2009
Human embryonic stem cell technologies and drug discoveryJanne Jensen, Johan Hyllner, Petter Björquist
Pharmacological Research|July 1, 2008
Low molecular weight compounds for in vitro fate determination of human embryonic stem cellsPeter Sartipy, Raimund Strehl, Petter Björquist, et al.
Drug Discovery Today|September 11, 2007
The application of human embryonic stem cell technologies to drug discoveryPeter Sartipy, Petter Björquist, Raimund Strehl, et al.
Biochemical Pharmacology|July 27, 2011
OATP1B1/1B3 activity in plated primary human hepatocytes over time in cultureMaria Ulvestad, Petter Björquist, Espen Molden, et al.
Stem Cells and Development|September 14, 2012
Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactorLouise Sivertsson, Jane Synnergren, Janne Jensen, et al.
Critical Reviews in Oncology/Hematology|August 11, 2007
Human embryonic stem cells: current technologies and emerging industrial applicationsCaroline Améen, Raimund Strehl, Petter Björquist, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 2, 2006
Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytesAnders Norström, Karolina Akesson, Thorir Hardarson, et al.
Thrombosis and Haemostasis|February 8, 2003
Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasmaJudith Leurs, Britt-Marie Wissing, Viveca Nerme, et al.
Pageof 4